Holen Sie sich die Stockscreener-App
1.59
0.57%
0.00
Waldencast Plc Aktie (WALD) Neueste Nachrichten
Quarterly Trades: Can Waldencast plc Equity Warrant navigate macro headwindsJuly 2025 Analyst Calls & Community Consensus Trade Alerts - baoquankhu1.vn
WALD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
WALD Should I Buy - Intellectia AI
Obagi Medical and Schweiger Dermatology Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ - The Globe and Mail
Schweiger clinics to trial new Obagi injectable in real-world ALOHA program - Stock Titan
New Highs: Is Waldencast plc Equity Warrant stock a value trapEarnings Growth Report & AI Driven Stock Price Forecasts - baoquankhu1.vn
Guidance Update: Can Waldencast plc Equity Warrant outperform in the next rallyFed Meeting & AI Forecasted Entry and Exit Points - baoquankhu1.vn
Obagi Medical and It's a Secret Med Spa announce collaboration in the Aloha program - marketscreener.com
Luxury med spa chain to evaluate Obagi’s new ALOHA hyaluronic injectable - Stock Titan
Does Waldencast plc Equity Warrant have a sustainable dividendIPO Watch & Weekly Return Optimization Alerts - mfd.ru
Will Waldencast plc Equity Warrant face regulatory challengesMarket Sentiment Summary & Weekly Breakout Stock Alerts - mfd.ru
How The Waldencast (WALD) Narrative Is Shifting As Outlook Resets Meet Brand Optimism - Yahoo Finance
Earnings Report: Can Waldencast plc Equity Warrant navigate macro headwindsLong Setup & Real-Time Buy Zone Alerts - baoquankhu1.vn
Waldencast plc (WALD) Acquired Novaestiq Corp. and the US Rights to the Saypha Line of Hyaluronic Acid Injectable Gels - MSN
Waldencast outlines mid-teens revenue growth for 2025 backed by brand expansion - MSN
Downgrade Watch: Can Waldencast plc Equity Warrant outperform in the next rallyTrade Signal Summary & Daily Stock Trend Watchlist - baoquankhu1.vn
Obagi Medical and Aesthetic Record Announce Collaboration - GlobeNewswire
How Obagi is testing a new hyaluronic acid injectable in real clinics - Stock Titan
Waldencast PLC (NASDAQ:WALD) Receives Average Recommendation of “Moderate Buy” from Analysts - Defense World
Is Waldencast plc stock positioned well for digital economy2025 Major Catalysts & Reliable Price Action Trade Plans - mfd.ru
Is Waldencast plc likely to announce a buybackQuarterly Market Summary & Free Verified High Yield Trade Plans - mfd.ru
Is Waldencast plc stock resilient to inflationMarket Growth Review & Real-Time Volume Analysis Alerts - mfd.ru
Is Waldencast plc Equity Warrant stock a value trapJuly 2025 Update & High Conviction Trade Alerts - mfd.ru
Why analysts remain bullish on Waldencast plc Equity Warrant stockJuly 2025 Earnings & Fast Gaining Stock Reports - mfd.ru
Is Waldencast plc Equity Warrant stock a top momentum play2025 Price Momentum & Weekly High Momentum Picks - mfd.ru
Waldencast: Strategic Reviews Are More Than Necessary (NASDAQ:WALD) - Seeking Alpha
Why Waldencast plc stock attracts high net worth investorsQuarterly Growth Report & Technical Entry and Exit Tips - mfd.ru
WALDWaldencast plc Latest Stock News & Market Updates - Stock Titan
Dividend Watch: What is the long term forecast for Waldencast plc stockMarket Risk Report & Community Shared Stock Ideas - baoquankhu1.vn
How The Story Behind Waldencast (WALD) Is Shifting In Analysts’ Eyes - Yahoo Finance UK
Obagi Medical names DermFx as partner for hyaluronic acid program - Investing.com South Africa
Obagi Medical and DermFx Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™ - The Manila Times
SoCal med spa DermFx to evaluate Obagi MagIQ injectable in daily practice - Stock Titan
Obagi Medical and DermFx Announce Collaboration in the - GlobeNewswire
Retail Surge: Is Waldencast plc Equity Warrant a strong growth stockMarket Activity Recap & Verified Technical Trade Signals - baoquankhu1.vn
Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ - The Globe and Mail
Obagi Medical and Moxie Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™ - The Manila Times
Obagi Medical and Moxie Announce Collaboration in the ALOHA - GlobeNewswire
Aug Technicals: Will Waldencast plc benefit from rising consumer demandMarket Risk Report & Free Expert Approved Momentum Trade Ideas - baoquankhu1.vn
Obagi Medical Introduces New Lip Therapy Protocol Designed to Resurface, Replenish, and Protect - Finviz
New Obagi two-step lip peel aims for smoother, protected lips - Stock Titan
How strong is Waldencast plc Equity Warrant stock revenue growth2025 Major Catalysts & Smart Swing Trading Techniques - mfd.ru
US Market Wrap: Is Waldencast plc Equity Warrant a strong growth stock2025 Earnings Impact & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Waldencast PLC (NASDAQ:WALD) Short Interest Down 25.7% in January - MarketBeat
VIO Med Spa to test Obagi MagIQ filler in nationwide clinics - Stock Titan
Obagi Medical and VIO Med Spa Announce Collaboration in the - GlobeNewswire
Inside Obagi’s plan to test a new injectable across Next Health wellness centers - Stock Titan
Obagi Medical and Next Health Announce Collaboration in the - GlobeNewswire
UPDATEObagi Medical and Alpha Aesthetic Partners - GlobeNewswire
Obagi filler to be studied across 31 Alpha medspa locations - stocktitan.net
Obagi Medical and Alpha Aesthetic Partners Announce Their - GlobeNewswire
Published on: 2026-01-27 01:38:51 - baoquankhu1.vn
CORRECTIONObagi Medical and Platinum Dermatology Partners Announce Collaboration in the ALOHA Program to Drive Real-World Evidence for Obagi® saypha® MagIQ™ - The Manila Times
CORRECTION – Obagi Medical and Platinum Dermatology - GlobeNewswire
Obagi Medical and Platinum Dermatology Partners Announce - GlobeNewswire
Platinum’s 120-clinic network to trial Obagi’s new MagIQ injectable - Stock Titan
Waldencast PLC (NASDAQ:WALD) Receives $4.42 Consensus Price Target from Brokerages - Defense World
Can Waldencast plc disrupt its industryWeekly Trend Summary & Reliable Volume Spike Alerts - mfd.ru
Waldencast PLC (NASDAQ:WALD) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Obagi Medical Unveils ALOHA Program to Launch Obagi® - GlobeNewswire
Can Waldencast plc Equity Warrant outperform in the next rallyJuly 2025 Closing Moves & Weekly High Return Stock Opportunities - bollywoodhelpline.com
Waldencast PLC (NASDAQ:WALD) Sees Large Drop in Short Interest - MarketBeat
1.22%
3.02%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):